Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare.

Published in: Therapeutic advances in musculoskeletal disease (2021)

Shorter LDA duration (cut-off value: 5.3 months) and lower time-averaged DQ (cut-off value: 60.6%) were associated with a higher risk of flare after tapering TNFi.

Keyphrases

ankylosing spondylitis
disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
juvenile idiopathic arthritis